Protalix BioTherapeutics Reports Fiscal Year 2021 Financial and Business Results

Go back to Protalix BioTherapeutics Reports Fiscal Year 2021 Financial and Business Results
POWERSHARES GLOBAL CLEAN ENERGY PORTFOLIO (NYSE: PBD) Delayed: 17.53 --0 (-0%)
Previous Close $17.53    52 Week High $11.63 
Open $17.53    52 Week Low $9.19 
Day High $17.53    P/E N/A 
Day Low $17.53    EPS $0.00 
Volume 41       

POWERSHARES GLOBAL CLEAN ENERGY PORTFOLIO (NYSE: PBD) Delayed: 17.53 --0 (-0%)
Previous Close $17.53    52 Week High $11.63 
Open $17.53    52 Week Low $9.19 
Day High $17.53    P/E N/A 
Day Low $17.53    EPS $0.00 
Volume 41       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.64 --0 (-0%)
Previous Close $2.64    52 Week High $1.11 
Open $2.64    52 Week Low $0.41 
Day High $2.64    P/E N/A 
Day Low $2.64    EPS $-0.29 
Volume 84       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.64 --0 (-0%)
Previous Close $2.64    52 Week High $1.11 
Open $2.64    52 Week Low $0.41 
Day High $2.64    P/E N/A 
Day Low $2.64    EPS $-0.29 
Volume 84